News Release

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

April 26, 2012

Change of the Name of Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd.

Tokyo, Japan, April 26, 2012 --- "Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd.," a subsidiary of Kyowa Hakko Kirin Co., Ltd., ("Kyowa Hakko Kirin") and engaged in developing, manufacturing, and selling ethical drugs in China, changed its name to "Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.," effective April 23, 2012.

<Reason for the change>
Kyowa Hakko Kirin took full ownership of Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd., as a fully owned subsidiary in 2010.

Outline of Kyowa Hakko Kirin China Pharmaceutical Co., Ltd.

Established June 26, 1997
Located 970 Long Dong Road, Z. J. High-Tech Park, Pudong New Area, Shanghai, China 201203
General Manager Toshihiro Onodera
Capital 29.8 million U.S. dollars
Shareholder Kyowa Hakko Kirin Co., Ltd. (100%)
Sales 230 million CNY (2011)
Business Areas Development, manufacturing, and sale of ethical drugs in China
Main Office Head office, factory: Shanghai
Office: Beijing, Guangzhou, Hangzhou, Chengdu, Hefei

To Page Top